Outputs (2)

“One Blood Clot Is One Too Many”: Affected Vocal Users’ Negative Perspectives on Controversial Oral Contraceptives (2019)
Journal Article
Geampana, A. (2019). “One Blood Clot Is One Too Many”: Affected Vocal Users’ Negative Perspectives on Controversial Oral Contraceptives. Qualitative Health Research, 29(10), 1519-1530. https://doi.org/10.1177/1049732319839027

In this article, I analyze women’s negative experiences with the fourth generation of contraceptive pills: controversial drugs Yaz and Yasmin. Drawing on in-depth interviews with 24 contraceptive users residing in Canada, I highlight how women who ha... Read More about “One Blood Clot Is One Too Many”: Affected Vocal Users’ Negative Perspectives on Controversial Oral Contraceptives.

Risky Technologies: Systemic Uncertainty in Contraceptive Risk Assessment and Management (2019)
Journal Article
Geampana, A. (2019). Risky Technologies: Systemic Uncertainty in Contraceptive Risk Assessment and Management. Science, Technology, & Human Values, 44(6), 1116-1138. https://doi.org/10.1177/0162243919831411

Focusing on the controversial birth control pills Yaz and Yasmin, this article explores how debates about the safety of these drugs have materialized in risk evaluations and the management of technological risk. Drawing on in-depth interviews with st... Read More about Risky Technologies: Systemic Uncertainty in Contraceptive Risk Assessment and Management.